Logo image of AHCO

ADAPTHEALTH CORP (AHCO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AHCO - US00653Q1022 - Common Stock

9.75 USD
+0.09 (+0.93%)
Last: 12/1/2025, 8:00:00 PM
9.75 USD
0 (0%)
After Hours: 12/1/2025, 8:00:00 PM
Fundamental Rating

5

AHCO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While AHCO is still in line with the averages on profitability rating, there are concerns on its financial health. AHCO scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year AHCO was profitable.
AHCO had a positive operating cash flow in the past year.
In multiple years AHCO reported negative net income over the last 5 years.
Each year in the past 5 years AHCO had a positive operating cash flow.
AHCO Yearly Net Income VS EBIT VS OCF VS FCFAHCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

AHCO's Return On Assets of 1.69% is in line compared to the rest of the industry. AHCO outperforms 56.44% of its industry peers.
Looking at the Return On Equity, with a value of 4.83%, AHCO is in the better half of the industry, outperforming 61.39% of the companies in the same industry.
AHCO has a Return On Invested Capital of 4.53%. This is comparable to the rest of the industry: AHCO outperforms 52.48% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AHCO is below the industry average of 9.22%.
The 3 year average ROIC (4.25%) for AHCO is below the current ROIC(4.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.69%
ROE 4.83%
ROIC 4.53%
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
AHCO Yearly ROA, ROE, ROICAHCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

AHCO's Profit Margin of 2.33% is fine compared to the rest of the industry. AHCO outperforms 64.36% of its industry peers.
AHCO's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 7.82%, AHCO is doing good in the industry, outperforming 72.28% of the companies in the same industry.
AHCO's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 25.32%, AHCO is in line with its industry, outperforming 50.49% of the companies in the same industry.
AHCO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.82%
PM (TTM) 2.33%
GM 25.32%
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
AHCO Yearly Profit, Operating, Gross MarginsAHCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AHCO is destroying value.
Compared to 1 year ago, AHCO has more shares outstanding
The number of shares outstanding for AHCO has been increased compared to 5 years ago.
Compared to 1 year ago, AHCO has an improved debt to assets ratio.
AHCO Yearly Shares OutstandingAHCO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AHCO Yearly Total Debt VS Total AssetsAHCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.06, we must say that AHCO is in the distress zone and has some risk of bankruptcy.
AHCO has a Altman-Z score of 1.06. This is in the lower half of the industry: AHCO underperforms 68.32% of its industry peers.
AHCO has a debt to FCF ratio of 9.48. This is a negative value and a sign of low solvency as AHCO would need 9.48 years to pay back of all of its debts.
AHCO's Debt to FCF ratio of 9.48 is in line compared to the rest of the industry. AHCO outperforms 45.54% of its industry peers.
AHCO has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.27, AHCO is doing worse than 63.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 9.48
Altman-Z 1.06
ROIC/WACC0.58
WACC7.83%
AHCO Yearly LT Debt VS Equity VS FCFAHCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.33 indicates that AHCO should not have too much problems paying its short term obligations.
With a Current ratio value of 1.33, AHCO perfoms like the industry average, outperforming 47.52% of the companies in the same industry.
A Quick Ratio of 1.09 indicates that AHCO should not have too much problems paying its short term obligations.
AHCO has a Quick ratio (1.09) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.09
AHCO Yearly Current Assets VS Current LiabilitesAHCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

AHCO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 119.39%, which is quite impressive.
The Earnings Per Share has been growing by 10.23% on average over the past years. This is quite good.
The Revenue for AHCO has decreased by -19.72% in the past year. This is quite bad
AHCO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.84% yearly.
EPS 1Y (TTM)119.39%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%6.67%
Revenue 1Y (TTM)-19.72%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%1.79%

3.2 Future

Based on estimates for the next years, AHCO will show a very strong growth in Earnings Per Share. The EPS will grow by 20.59% on average per year.
Based on estimates for the next years, AHCO will show a small growth in Revenue. The Revenue will grow by 7.27% on average per year.
EPS Next Y36.57%
EPS Next 2Y37.29%
EPS Next 3Y30.76%
EPS Next 5Y20.59%
Revenue Next Year-0.24%
Revenue Next 2Y3.24%
Revenue Next 3Y5.33%
Revenue Next 5Y7.27%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AHCO Yearly Revenue VS EstimatesAHCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
AHCO Yearly EPS VS EstimatesAHCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.47, the valuation of AHCO can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as AHCO.
AHCO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.62, the valuation of AHCO can be described as very reasonable.
94.06% of the companies in the same industry are more expensive than AHCO, based on the Price/Forward Earnings ratio.
AHCO is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.47
Fwd PE 8.62
AHCO Price Earnings VS Forward Price EarningsAHCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AHCO indicates a rather cheap valuation: AHCO is cheaper than 93.07% of the companies listed in the same industry.
95.05% of the companies in the same industry are more expensive than AHCO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.19
EV/EBITDA 5.11
AHCO Per share dataAHCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AHCO has a very decent profitability rating, which may justify a higher PE ratio.
AHCO's earnings are expected to grow with 30.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y37.29%
EPS Next 3Y30.76%

0

5. Dividend

5.1 Amount

No dividends for AHCO!.
Industry RankSector Rank
Dividend Yield N/A

ADAPTHEALTH CORP

NASDAQ:AHCO (12/1/2025, 8:00:00 PM)

After market: 9.75 0 (0%)

9.75

+0.09 (+0.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners93.9%
Inst Owner Change-0.75%
Ins Owners1.82%
Ins Owner Change1.38%
Market Cap1.32B
Revenue(TTM)3.26B
Net Income(TTM)75.81M
Analysts81.43
Price Target13.52 (38.67%)
Short Float %8.81%
Short Ratio9.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-123.07%
Min EPS beat(2)-210.83%
Max EPS beat(2)-35.31%
EPS beat(4)1
Avg EPS beat(4)-384.03%
Min EPS beat(4)-1325.49%
Max EPS beat(4)35.5%
EPS beat(8)1
Avg EPS beat(8)-358.04%
EPS beat(12)3
Avg EPS beat(12)-235.24%
EPS beat(16)3
Avg EPS beat(16)-191.39%
Revenue beat(2)1
Avg Revenue beat(2)-0.88%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.19%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.28%
Revenue beat(8)4
Avg Revenue beat(8)-0.23%
Revenue beat(12)5
Avg Revenue beat(12)-0.64%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)0.95%
PT rev (3m)0.95%
EPS NQ rev (1m)-9.74%
EPS NQ rev (3m)-15.09%
EPS NY rev (1m)1.69%
EPS NY rev (3m)-14.84%
Revenue NQ rev (1m)-1.81%
Revenue NQ rev (3m)-1.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE 30.47
Fwd PE 8.62
P/S 0.41
P/FCF 6.19
P/OCF 2.32
P/B 0.84
P/tB N/A
EV/EBITDA 5.11
EPS(TTM)0.32
EY3.28%
EPS(NY)1.13
Fwd EY11.6%
FCF(TTM)1.57
FCFY16.15%
OCF(TTM)4.2
OCFY43.09%
SpS24.04
BVpS11.6
TBVpS-8.93
PEG (NY)0.83
PEG (5Y)N/A
Graham Number9.14
Profitability
Industry RankSector Rank
ROA 1.69%
ROE 4.83%
ROCE 6.5%
ROIC 4.53%
ROICexc 4.66%
ROICexgc 17.24%
OM 7.82%
PM (TTM) 2.33%
GM 25.32%
FCFM 6.55%
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
ROICexc(3y)4.34%
ROICexc(5y)3.9%
ROICexgc(3y)17.05%
ROICexgc(5y)18.83%
ROCE(3y)6.1%
ROCE(5y)5.39%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y-13.24%
ROICexc growth 3Y18.04%
ROICexc growth 5Y-2.96%
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
F-Score7
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 9.48
Debt/EBITDA 3.16
Cap/Depr 94.9%
Cap/Sales 10.93%
Interest Coverage 2.41
Cash Conversion 90.37%
Profit Quality 281.18%
Current Ratio 1.33
Quick Ratio 1.09
Altman-Z 1.06
F-Score7
WACC7.83%
ROIC/WACC0.58
Cap/Depr(3y)94.46%
Cap/Depr(5y)82.09%
Cap/Sales(3y)11.04%
Cap/Sales(5y)9.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.39%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%6.67%
EPS Next Y36.57%
EPS Next 2Y37.29%
EPS Next 3Y30.76%
EPS Next 5Y20.59%
Revenue 1Y (TTM)-19.72%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%1.79%
Revenue Next Year-0.24%
Revenue Next 2Y3.24%
Revenue Next 3Y5.33%
Revenue Next 5Y7.27%
EBIT growth 1Y-29.64%
EBIT growth 3Y12.08%
EBIT growth 5Y59.71%
EBIT Next Year170.35%
EBIT Next 3Y49.37%
EBIT Next 5YN/A
FCF growth 1Y594.38%
FCF growth 3Y48.23%
FCF growth 5Y43.24%
OCF growth 1Y34.71%
OCF growth 3Y25.26%
OCF growth 5Y55.08%

ADAPTHEALTH CORP / AHCO FAQ

What is the ChartMill fundamental rating of ADAPTHEALTH CORP (AHCO) stock?

ChartMill assigns a fundamental rating of 5 / 10 to AHCO.


Can you provide the valuation status for ADAPTHEALTH CORP?

ChartMill assigns a valuation rating of 7 / 10 to ADAPTHEALTH CORP (AHCO). This can be considered as Undervalued.


How profitable is ADAPTHEALTH CORP (AHCO) stock?

ADAPTHEALTH CORP (AHCO) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for AHCO stock?

The Price/Earnings (PE) ratio for ADAPTHEALTH CORP (AHCO) is 30.47 and the Price/Book (PB) ratio is 0.84.